Paclitaxel-loaded redox-sensitive nanoparticles based on hyaluronic acid-vitamin E succinate conjugates for improved lung cancer treatment

Abstract

BackgroundLung cancer is the primary cause of cancer-related death worldwide. A redox-sensitive nanocarrier system was developed for tumor-targeted drug delivery and sufficient drug release of the chemotherapeutic agent paclitaxel (PTX) for improved lung cancer treatment.MethodsThe redox-sensitive nanocarrier system constructed from a hyaluronic acid-disulfide-vitamin E succinate (HA-SS-VES, HSV) conjugate was synthesized and PTX was loaded in the delivery system. The physicochemical properties of the HSV nanoparticles were characterized. The redox-sensitivity, tumor-targeting and intracellular drug release capability of the HSV nanoparticles were evaluated. Furthermore, in vitro and in vivo antitumor activity of the PTX-loaded HSV nanoparticles was investigated in a CD44 over-expressed A549 tumor model.ResultsThis HSV conjugate was successfully synthesized and self-assembled to form nanoparticles in aqueous condition with a low critical micelle concentration of 36.3 μg mL−1. Free PTX was successfully entrapped into the HSV nanoparticles with a high drug loading of 33.5% (w/w) and an entrapment efficiency of 90.6%. Moreover, the redox-sensitivity of the HSV nanoparticles was confirmed by particle size change of the nanoparticles along with in vitro release profiles in different reducing environment. In addition, the HA-receptor mediated endocytosis and the potency of redox-sensitivity for intracellular drug delivery were further verified by flow cytometry and confocal laser scanning microscopic analysis. The antitumor activity results showed that compared to redox-insensitive nanoparticles and Taxol®, PTX-loaded redox-sensitive nanoparticles exhibited much greater in vitro cytotoxicity and apoptosis-inducing ability against CD44 over-expressed A549 tumor cells. In vivo, the PTX-loaded HSV nanoparticles possessed much higher antitumor efficacy in an A549 mouse xenograft model and demonstrated improved safety profile. In summary, our PTX-loaded redox-sensitive HSV nanoparticles demonstrated enhanced antitumor efficacy and improved safety of PTX.ConclusionThe results of our study indicated the redox-sensitive HSV nanoparticle was a promising nanocarrier for lung cancer therapy.

Glycosaminoglycan and Proteoglycan Biotherapeutics in Articular Cartilage Protection and Repair Strategies: Novel Approaches to Visco‐supplementation in Orthobiologics

“…Targeted drug delivery with enhanced anti-tumor efficacy Targeted drug delivery system HA oligomer-HPMA copolymer conjugated paclitaxel targeted to CD44-overexpressing ovarian tumors Micellar targeted intracellular delivery of paclitaxel Targeting of human squamous cell carcinomas of the head and neck Intracellular anti-tumor targeting Intracellular anti-tumor drug delivery HA-paclitaxel prodrugs for direct cytosolic delivery and enhanced anti-tumor activity Broad anti-cancer treatment Improved anti-tumor activity and safety delivery of paclitaxel [369] [370]…”

Redox-Sensitive and Hyaluronic Acid-Functionalized Nanoparticles for Improving Breast Cancer Treatment by Cytoplasmic 17α-Methyltestosterone Delivery

“…Nanoparticles (NPs) are vehicles that can prolong drug circulation time, transfer hydrophobic drugs, enhance the accumulation of drugs in tumor tissues through enhanced permeability and retention effect, and reduce normal tissue toxicity. Therefore, various kinds of NPs, including liposomes, micelles, and magnetic NPs, were fabricated to enhance the therapeutic effects of anticancer drugs [7][8][9]. However, inefficient drug release of the traditional micelles at the tumor site restricts the therapeutic outcomes.…”

Insights on Cancer Preventive Approaches Using Plant Based Extracts

“…Therefore, a research study was conducted to explore the effects of Stephania kwangsiensis root tubers on the proliferation and apoptosis of the NCI-H446 cells-a lung adenocarcinoma model. The results demonstrated that corydine has marked cytostatic and proapoptotic effects on human small cell lung cancer [56,57].…”

“…The PTX-loaded redox-sensitive nanoparticles has shown greater in vitro cytotoxicity and apoptosis-inducing ability against CD44 over-expressed A549 tumor cells in comparison to the redox-insensitive nanoparticles [53]. In an in-vivo study, the PTX-loaded HSV nanoparticles exhibited an enhanced antitumor efficacy in a A549 mouse xenograft model [54].…”